Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 204

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 204
---
 Notes could allow for the PIPE Investors to convert such notes into shares of New Profusa Common Stock at a price substantially below the redemption price which could be received by NorthView public stockholders. Similarly, the holders of Profusa’s Convertible Bridge Loans are expected to convert into shares of Profusa capital stock, and subsequently convert into shares of New Profusa common Stock at an effective price of $2.22 per share. Each of these effective prices is or could be substantially below the redemption price of the NorthView Common Stock. Accordingly, the issuance of shares in connection with the conversion of the PIPE Convertible Notes and conversion of the Convertible Bridge Loan could have a negative impact on the value of the New Profusa Common Stock. Future sales, or the perception of future sales, by New Profusa shareholders in the public market following the Business Combination could cause the market price for New Profusa Common Stock to decline. The sale of shares of New Profusa Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of New Profusa Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for New Profusa to sell equity securities in the future at a time and at a price that it deems appropriate. Upon consummation of the Business Combination, a total of approximately 33,323,824 shares of New Profusa Common Stock will be outstanding (assuming a maximum redemption scenario), and 300,000,000 shares authorized for issuance. All shares issued in the Business Combination will be freely tradable without registration under the Securities Act, and without restriction by persons other than New Profusa’s “affiliates” (as defined under Rule 144 of the Securities Act, “Rule 144”), including New Profusa’s directors, executive officers and other affiliates. Contemporaneous with the Closing, New Profusa will enter into certain agreements restricting the transfer of New Profusa securities held by certain parties immediately following the Closing, including the Stockholder Support Agreements and the Sponsor Lock -UpAgreements. See the section entitled “ Proposal 1: The Business Combination Proposal — Related Agreements” for a further discussion of the Stockholder Support Agreements and Sponsor Lock -UpAgreements. 92 The grant and future exercise of registration rights may adversely affect the market price of New Profusa shares upon consummation of the Business Combination. Pursuant to the Registration Rights Agreement to be entered into in connection with the Business Combination and which